tiprankstipranks
Axsome Therapeutics Inc (GB:0HKF)
LSE:0HKF
UK Market

Axsome Therapeutics (0HKF) Income Statement

Compare
2 Followers

Axsome Therapeutics Income Statement

Last quarter (Q4 2024), Axsome Therapeutics's total revenue was $118.77M, an increase of 66.04% from the same quarter last year. In Q4, Axsome Therapeutics's net income was $-74.91M. See Axsome Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 385.69M$ 270.60M$ 50.04M$ 0.00$ 0.00
Gross Profit
$ 352.39M$ 244.53M$ 44.84M$ -1.16M$ -77.72K
Operating Expenses
$ 632.95M$ 476.36M$ 221.34M$ 124.71M$ 99.09M
Depreciation and Amortization
$ 0.00$ 6.83M$ 5.56M$ 1.16M$ 77.72K
EBITDA
$ -280.56M$ -224.99M$ -174.23M$ -123.55M$ -99.06M
Operating Income
$ -280.56M$ -231.82M$ -176.50M$ -124.71M$ -99.14M
Other Income/Expenses
$ -6.57M$ -6.45M$ -7.33M$ -5.70M$ -3.81M
Pretax Income
$ -287.13M$ -238.28M$ -187.13M$ -130.40M$ -102.90M
Net Income
$ -287.22M$ -239.24M$ -197.77M$ -134.94M$ -105.39M
Per Share Metrics
Basic EPS
$ -5.99$ -5.27$ -4.86$ -3.59$ -2.83
Diluted EPS
$ -5.99$ -5.27$ -4.86$ -3.59$ -2.83
Weighted Average Shares Outstanding
47.91M 45.43M 40.66M 37.62M 37.21M
Weighted Average Shares Outstanding (Diluted)
47.91M 45.43M 40.66M 37.62M 37.21M
Currency in USD

Axsome Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis